Friday 4^th April 2014

14:00      Welcome (R. Stahel, Zürich)

I The Bases for cancer immune therapy

14:15      Basic immunology (N. Rufer, Lausanne)

14:35      Vaccines (N. Rufer, Lausanne)

14:55      Check Point Inhibitors (U. Petrausch, Zürich)

15:15      T cell engineering (L. Kandalaft, Lausanne)

15:35      Coffee break

II Immunotherapy as a transversal innovative anti cancer strategy           

Melanoma

16:00      Check points inhibitors (O. Michielin, Lausanne)

16:25      Adoptive transfer (O. Michielin, Lausanne)

16:50      Perspectives/ongoing research strategy in the local network (O. Michielin, Lausanne)

Ovarian Cancer

17:00      Immunotherapy for ovarian cancer (L. Kandalaft, Lausanne)

17:30      Perspectives/ongoing research strategy in the local network (L. Kandalaft, Lausanne)

GU Cancer

17:40      Immunotherapy for prostate cancer (C. Sessa, Bellinzona)

18:10      Perspectives/ongoing research strategy in the local network (C. Sessa, Bellinzona)

18:20      Adjourn

Saturday 5^th April 2014

Lung Cancer

08:00      Check points inhibitors (L. Paz-Ares, Sevilla)

08:30      Vaccines in lung cancer (J. Vansteenkiste, Leuven)

09:00      Perspectives/ongoing research strategy in the local network (S. Peters, Lausanne)

Breast Cancer

09:10      Immunotherapy for breast cancer (G. Curigliano, Milano)

09:50      Coffee break

Haematological malignancies

10:20      Immunotherapy for lymphoma and leukemia (A. Stathis, Bellinzona)

10:50      Perspectives/ongoing research strategy in the local network (A. Stathis, Bellinzona)

Brain tumors

11:00      Immunotherapy for CNS malignancies (P.-Y. Dietrich, Genève)

11:30      Perspectives/ongoing research strategy in the local network (P.-Y. Dietrich, Genève)

11:40      Wrap-up and conclusions (R. Stahel, Zürich)

12:00      End